FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308486535> ?p ?o ?g. }

• W4308486535 endingPage "117" @default.
• W4308486535 startingPage "110" @default.
• W4308486535 abstract "BackgroundThe global epidemiology of asthma among patients with coronavirus disease 2019 (COVID-19) presents striking geographic differences, defining prevalence zones of high and low co-occurrence of asthma and COVID-19.ObjectiveWe aimed to compare asthma prevalence among hospitalized patients with COVID-19 in major global hubs across the world by applying common inclusion criteria and definitions.MethodsWe built a network of 6 academic hospitals in Stanford (Stanford University)/the United States; Frankfurt (Goethe University), Giessen (Justus Liebig University), and Marburg (Philipps University)/Germany; and Moscow (Clinical Hospital 52 in collaboration with Sechenov University)/Russia. We collected clinical and laboratory data for patients hospitalized due to COVID-19.ResultsAsthmatic individuals were overrepresented among hospitalized patients with COVID-19 in Stanford and underrepresented in Moscow and Germany as compared with their prevalence among adults in the local community. Asthma prevalence was similar among patients hospitalized in an intensive care unit and patients hospitalized in other than an intensive care unit, which implied that the risk for development of severe COVID-19 was not higher among asthmatic patients. The numbers of males and comorbidities were higher among patients with COVID-19 in the Stanford cohort, and the most frequent comorbidities among these patients with asthma were other chronic inflammatory airway disorders such as chronic obstructive pulmonary disease.ConclusionThe observed disparity in COVID-19–associated risk among asthmatic patients across countries and continents is connected to the varying prevalence of underlying comorbidities, particularly chronic obstructive pulmonary disease. The global epidemiology of asthma among patients with coronavirus disease 2019 (COVID-19) presents striking geographic differences, defining prevalence zones of high and low co-occurrence of asthma and COVID-19. We aimed to compare asthma prevalence among hospitalized patients with COVID-19 in major global hubs across the world by applying common inclusion criteria and definitions. We built a network of 6 academic hospitals in Stanford (Stanford University)/the United States; Frankfurt (Goethe University), Giessen (Justus Liebig University), and Marburg (Philipps University)/Germany; and Moscow (Clinical Hospital 52 in collaboration with Sechenov University)/Russia. We collected clinical and laboratory data for patients hospitalized due to COVID-19. Asthmatic individuals were overrepresented among hospitalized patients with COVID-19 in Stanford and underrepresented in Moscow and Germany as compared with their prevalence among adults in the local community. Asthma prevalence was similar among patients hospitalized in an intensive care unit and patients hospitalized in other than an intensive care unit, which implied that the risk for development of severe COVID-19 was not higher among asthmatic patients. The numbers of males and comorbidities were higher among patients with COVID-19 in the Stanford cohort, and the most frequent comorbidities among these patients with asthma were other chronic inflammatory airway disorders such as chronic obstructive pulmonary disease. The observed disparity in COVID-19–associated risk among asthmatic patients across countries and continents is connected to the varying prevalence of underlying comorbidities, particularly chronic obstructive pulmonary disease." @default.
• W4308486535 created "2022-11-12" @default.
• W4308486535 creator A5003883433 @default.
• W4308486535 creator A5004007739 @default.
• W4308486535 creator A5028760615 @default.
• W4308486535 creator A5041608462 @default.
• W4308486535 creator A5042981268 @default.
• W4308486535 creator A5043108354 @default.
• W4308486535 creator A5044730303 @default.
• W4308486535 creator A5050108806 @default.
• W4308486535 creator A5050579407 @default.
• W4308486535 creator A5051999082 @default.
• W4308486535 creator A5053003825 @default.
• W4308486535 creator A5058805192 @default.
• W4308486535 creator A5060402481 @default.
• W4308486535 creator A5078675502 @default.
• W4308486535 creator A5080756715 @default.
• W4308486535 creator A5089509555 @default.
• W4308486535 date "2023-01-01" @default.
• W4308486535 modified "2023-10-12" @default.
• W4308486535 title "Comorbidity defines asthmatic patients' risk of COVID-19 hospitalization: A global perspective" @default.
• W4308486535 cites W2137591261 @default.
• W4308486535 cites W2145025818 @default.
• W4308486535 cites W2295367661 @default.
• W4308486535 cites W2760886426 @default.
• W4308486535 cites W2767260905 @default.
• W4308486535 cites W2904062712 @default.
• W4308486535 cites W2949174534 @default.
• W4308486535 cites W3015696390 @default.
• W4308486535 cites W3016535995 @default.
• W4308486535 cites W3018108347 @default.
• W4308486535 cites W3025195557 @default.
• W4308486535 cites W3031103686 @default.
• W4308486535 cites W3036322515 @default.
• W4308486535 cites W3041985244 @default.
• W4308486535 cites W3088314701 @default.
• W4308486535 cites W3109999591 @default.
• W4308486535 cites W3110738325 @default.
• W4308486535 cites W3137670506 @default.
• W4308486535 cites W3201137856 @default.
• W4308486535 cites W4220961723 @default.
• W4308486535 cites W4223513566 @default.
• W4308486535 cites W4226160122 @default.
• W4308486535 doi "https://doi.org/10.1016/j.jaci.2022.09.039" @default.
• W4308486535 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36336123" @default.
• W4308486535 hasPublicationYear "2023" @default.
• W4308486535 type Work @default.
• W4308486535 citedByCount "2" @default.
• W4308486535 countsByYear W43084865352023 @default.
• W4308486535 crossrefType "journal-article" @default.
• W4308486535 hasAuthorship W4308486535A5003883433 @default.
• W4308486535 hasAuthorship W4308486535A5004007739 @default.
• W4308486535 hasAuthorship W4308486535A5028760615 @default.
• W4308486535 hasAuthorship W4308486535A5041608462 @default.
• W4308486535 hasAuthorship W4308486535A5042981268 @default.
• W4308486535 hasAuthorship W4308486535A5043108354 @default.
• W4308486535 hasAuthorship W4308486535A5044730303 @default.
• W4308486535 hasAuthorship W4308486535A5050108806 @default.
• W4308486535 hasAuthorship W4308486535A5050579407 @default.
• W4308486535 hasAuthorship W4308486535A5051999082 @default.
• W4308486535 hasAuthorship W4308486535A5053003825 @default.
• W4308486535 hasAuthorship W4308486535A5058805192 @default.
• W4308486535 hasAuthorship W4308486535A5060402481 @default.
• W4308486535 hasAuthorship W4308486535A5078675502 @default.
• W4308486535 hasAuthorship W4308486535A5080756715 @default.
• W4308486535 hasAuthorship W4308486535A5089509555 @default.
• W4308486535 hasBestOaLocation W43084865351 @default.
• W4308486535 hasConcept C107130276 @default.
• W4308486535 hasConcept C126322002 @default.
• W4308486535 hasConcept C177713679 @default.
• W4308486535 hasConcept C187212893 @default.
• W4308486535 hasConcept C201903717 @default.
• W4308486535 hasConcept C2776042228 @default.
• W4308486535 hasConcept C2776376669 @default.
• W4308486535 hasConcept C2776780178 @default.
• W4308486535 hasConcept C2779134260 @default.
• W4308486535 hasConcept C2779159551 @default.
• W4308486535 hasConcept C3008058167 @default.
• W4308486535 hasConcept C524204448 @default.
• W4308486535 hasConcept C71924100 @default.
• W4308486535 hasConcept C72563966 @default.
• W4308486535 hasConcept C89623803 @default.
• W4308486535 hasConceptScore W4308486535C107130276 @default.
• W4308486535 hasConceptScore W4308486535C126322002 @default.
• W4308486535 hasConceptScore W4308486535C177713679 @default.
• W4308486535 hasConceptScore W4308486535C187212893 @default.
• W4308486535 hasConceptScore W4308486535C201903717 @default.
• W4308486535 hasConceptScore W4308486535C2776042228 @default.
• W4308486535 hasConceptScore W4308486535C2776376669 @default.
• W4308486535 hasConceptScore W4308486535C2776780178 @default.
• W4308486535 hasConceptScore W4308486535C2779134260 @default.
• W4308486535 hasConceptScore W4308486535C2779159551 @default.
• W4308486535 hasConceptScore W4308486535C3008058167 @default.
• W4308486535 hasConceptScore W4308486535C524204448 @default.
• W4308486535 hasConceptScore W4308486535C71924100 @default.
• W4308486535 hasConceptScore W4308486535C72563966 @default.
• W4308486535 hasConceptScore W4308486535C89623803 @default.
• W4308486535 hasIssue "1" @default.

• next